Cargando…
Identification of Novel Tumor Markers in Prostate, Colon and Breast Cancer by Unbiased Methylation Profiling
DNA hypermethylation is a common epigenetic abnormality in cancer and may serve as a useful marker to clone cancer-related genes as well as a marker of clinical disease activity. To identify CpG islands methylated in prostate cancer, we used methylated CpG island amplification (MCA) coupled with rep...
Autores principales: | Chung, Woonbok, Kwabi-Addo, Bernard, Ittmann, Michael, Jelinek, Jaroslav, Shen, Lanlan, Yu, Yinhua, Issa, Jean-Pierre J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323612/ https://www.ncbi.nlm.nih.gov/pubmed/18446232 http://dx.doi.org/10.1371/journal.pone.0002079 |
Ejemplares similares
-
Identification of Novel Tumor Markers in Prostate, Colon and Breast Cancer by Unbiased Methylation Profiling
por: Chung, Woonbok, et al.
Publicado: (2008) -
Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer
por: Creighton, Chad J., et al.
Publicado: (2023) -
Correlating blood-based DNA methylation markers and prostate cancer risk in African-American men
por: Moses-Fynn, Emmanuel, et al.
Publicado: (2018) -
DNA Methylation Profiles of Primary Colorectal Carcinoma and Matched Liver Metastasis
por: Konishi, Kazuo, et al.
Publicado: (2011) -
Correlation between CpG methylation profiles and hormone receptor status in breast cancers
por: Feng, Weiwei, et al.
Publicado: (2007)